Edwards Lifesciences Corp. buy Royal Bank of Canada
Start price
07.02.24
/
50%
€80.68
Target price
07.02.25
€88.24
Performance (%)
0.11%
Price
26.04.24
€80.77
Summary
This prediction is currently active. The BUY prediction by Royal_Bank_of_Canada for Edwards Lifesciences Corp. is nearly unchanged. This prediction currently runs until 07.02.25. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Edwards Lifesciences Corp. | 0.161% | 0.161% |
iShares Core DAX® | 2.594% | -1.158% |
iShares Nasdaq 100 | 3.553% | -1.727% |
iShares Nikkei 225® | 0.687% | -8.354% |
iShares S&P 500 | 2.209% | -0.942% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Edwards Lifesciences Corp. diskutieren
Edwards Lifesciences Co. (NYSE: EW) had its price target raised by analysts at Royal Bank of Canada from $82.00 to $95.00. They now have an "outperform" rating on the stock.
Ratings data for EW provided by MarketBeat
Stopped prediction by Royal_Bank_of_Canada for Edwards Lifesciences Corp.
Edwards Lifesciences Corp.
Start price
Target price
Perf. (%)
€83.96
15.04.24
15.04.24
€95.04
15.04.25
15.04.25
-3.80%
26.04.24
26.04.24
Edwards Lifesciences Corp.
Start price
Target price
Perf. (%)
€67.68
12.01.24
12.01.24
€74.84
12.01.25
12.01.25
19.34%
26.04.24
26.04.24
Edwards Lifesciences Corp.
Start price
Target price
Perf. (%)
€60.38
26.10.23
26.10.23
€77.62
26.10.24
26.10.24
33.77%
26.04.24
26.04.24
Edwards Lifesciences Corp.
Start price
Target price
Perf. (%)
€71.40
17.08.23
17.08.23
€88.14
17.08.24
17.08.24
13.12%
26.04.24
26.04.24
Edwards Lifesciences Corp.
Start price
Target price
Perf. (%)
€74.66
01.08.23
01.08.23
€87.48
01.08.24
01.08.24
8.18%
26.04.24
26.04.24